Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent
Reexamination Certificate
2005-06-27
2009-11-24
Chang, Celia (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen in the nitrogen containing substituent
C514S227800
Reexamination Certificate
active
07622579
ABSTRACT:
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.
REFERENCES:
patent: WO 96/10022 (1996-04-01), None
patent: WO 97/06802 (1997-02-01), None
patent: WO 98/06705 (1998-02-01), None
patent: WO 03/068749 (2003-08-01), None
patent: WO 03/103669 (2003-12-01), None
patent: WO 2004/035549 (2004-04-01), None
patent: WO 2004/101546 (2004-11-01), None
Chemcats 2032356618 , RN 909501-10-6 (2007).
Lee et al. “anlysis of structure . . . ” Bioorg. Med. chem. v. 12, p. 3411-3420 (2004).
Suh et al. “Nobel non-vanilloid . . . ” Bioorg. Med. Chem. Lett. v.13, p. 4389-4393 (2003).
Szallasi et al. “Vanilloid receptor . . . ” J. Med. Chem. v. 47 (11) p. 2717-2723 (2004).
Brown, G.R. et al., “A Novel Series of 4-Piperidinopyridine and 4-Piperidinopyrimidine inhibitors of 2,3-Oxidosqualene Cyclase-Lanosterol Synthase”, Journal of Medicinal Chemistry, vol. 43, No. 26, 2000, pp. 4964-4972.
Brown, G.R. et al., “Novel 4-Piperidinopyridine Inhibitors of Oxidosqualene Cyclase-Lanosterol Synthase Derived by Consideration of Inhibitor pKa”, Bioorganic & Medicinal Chemistry Letters, vol. 11, 2001, pp. 2213-2216.
Walpole, C.S.J. et al., “The discovery of Capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin”, Journal of Medicinal chemistry, American Chemical Society, Washington, US, vol. 37, 1994, pp. 1942-1954.
Brown, G.R. et al., “A Novel Series of 4-Piperidinopyridine and 4-Piperidinopyrimidine inhibitors of 2,3-Oxidosqualene Cyclase-Lanosterol Synthase”, Journal of Medicinal Chemistry, vol. 43, No. 26, 2000, pp. 4964-4972.
Gaul Micheal D.
Hutta Daniel A.
Zhao Bao-Ping
Chang Celia
Janssen Pharmaceutica NV
LandOfFree
Hetero isonipecotic modulators of vanilloid VR1 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hetero isonipecotic modulators of vanilloid VR1 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hetero isonipecotic modulators of vanilloid VR1 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4068064